View in EDS

O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy.

Saved in:
Bibliographic Details
Title: O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy.
Authors: Ross, P.1, Hendlisz, A.2, Ajithkumar, T.3, Iwuji, C.4, Harris, M.5, Croagh, D.5, Aghmesheh, M.6, Nagrial, A.7, Nguyen, N.8, Nikfarjam, M.9, Wilson, N.10, Kenny, D.10, Turner, D.11, Wasan, H.12
Source: Annals of Oncology. 2020 Supplement 3, Vol. 31, p232-232. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.04.054